A candidate intranasal vaccine against Covid-19, jointly developed by US scientists and India’s Bharat Biotech, has completed clinical trials as both a standalone vaccine and a booster, the vacc...

Bharat Biotech International Limited (BBIL) on Monday said its COVID-19 intranasal vaccine (BBV154) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials pha...

Bharat Biotech International Limited (BBIL) on Friday announced that its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in paediatric subjects in phase II/III st...

German Ambassador to India and Bhutan, Walter J Lindner on Thursday said the government of the European nation will start recognizing Bharat Biotech's COVID-19 vaccine for travel purpose there fro...

The US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted the pause, according to a statement issued...

Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI. Pr...

India's drug regulator has granted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in the...

Sensory pleasure Sir — Sigmund Freud used the term, osphresiolagnia, to describe pleasure derived from smells. None will understand this better than a book lover; the enticing scent of a book, ...

Covaxin and Covishield boosters will be available to private hospitals at Rs 225 per dose under revised and lowered prices announced by vaccine makers on Saturday, a day before the booster campaign op...

India's Covid-vaccine manufacturing firm, Bharat Biotech on Sunday issued a clarification that there is " no impact on efficacy and safety of the Covid-19 vaccine Covaxin", after the&nbs...